Author: Dr. David Lowemann

FDA: All Doses of Zepbound, Mounjaro Now Available

All doses of Eli Lilly’s weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S. Food and Drug Administration’s updated shortage list showed on Friday. However, the regulator has not yet removed the drugs off its shortage list. Lilly’s Mounjaro has… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on August 2, 2024

Feeling judged by your doctor? You might be right

New research shows that many people believe they may be judged if they share mistaken beliefs with their care team — and that doctors really do take strongly negative views of patients who disclose incorrect or unreasonable beliefs. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the […]

Published on August 2, 2024

Eye-tracking study provides valuable insights into learning mathematics

Eye-tracking allows studying aspects that cannot be seen, for example, the thinking processes of a student solving a mathematical problem. Researchers have integrated eye-tracking into education and are using the technology to radically improve the teaching of mathematics. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the […]

Published on August 2, 2024